Inventor

Jon K. Reel

Inventor

Carmel, IN, US

Overview

1991–2016

Patent span

Chemistry

Primary field (CPC C)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds29%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%

A61KPreparations for medical, dental or toiletry purposes22%

C07CAcyclic or carbocyclic compounds14%

C07KPeptides10%

PatentTitleYear

9,469,632'6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists'2016 8,765,960'6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist'2014 8,188,069'Azepine derivatives as gamma-secretase inhibitors'2012 8,058,425'Purine derivatives as kinase inhibitors'2011 8,022,065'Purine derivatives as kinase inhibitors'2011 7,390,801'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2008 6,951,854'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2005 6,906,056'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2005 6,888,022'Methods and compounds for inhibiting Î²-amyloid peptide release and/or its synthesis'2005 6,861,558'Methods and compounds for inhibiting Î²-amyloid peptide release and/or its synthesis'2005 6,683,075'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use'2004 6,667,305'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,653,303'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,635,632'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,632,811'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,579,867'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,569,851'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,559,141'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,544,978'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,541,466'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,476,263'Compounds for inhibiting -amyloid peptide release and/or its synthesis'2002 6,399,628'N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds'2002 6,251,928'Treatment of alzheimer\'s disease employing inhibitors of cathepsin D'2001 6,211,235'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'2001 6,207,710'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'2001 6,194,416'Heterocyclic compounds and their use'2001 6,191,166'Methods and compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'2001 6,124,312'Heterocyclic compounds'2000 6,117,883'Heterocyclic compounds'2000 5,965,614'N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'1999 5,814,646'Inhibitors of amyloid beta-protein production'1998 5,747,517'Benzylidene rhodanines'1998 5,693,633'Angiotensin II antagonists'1997 5,643,926'Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof'1997 5,624,937'Chemical compounds as inhibitors of amyloid beta protein production'1997 5,612,360'Angiotensin II antagonists'1997 5,571,925'Angiotensin II antagonists'1996 5,569,768'Angiotensin II antagonists'1996 5,563,278'Angiotensin II antagonists'1996 5,556,981'Angiotensin II antagonist intermediates'1996 5,484,780'Angiotensin II antagonists'1996 5,401,851'Angiotensin II antagonists'1995 5,312,936'Angiotensin II antagonists'1994 5,300,514'Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof'1994 5,073,566'Angiotensin II antagonist 1,3-imidazoles and use thereas'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–2016Patents assigned to LILLY CO ELI (44)· patent assignee history

1991–1996Based in Indianapolis, IN, US· patent location history

1994–2016Based in Carmel, IN, US· patent location history

1999–2008Patents assigned to ATHENA NEUROSCIENCES INC (12)· patent assignee history

2001–2005Patents assigned to ELAN PHARM INC (5)· patent assignee history

2011–2012Patents assigned to REEL JON KEVIN (2)· patent assignee history

2011Patents assigned to BERRIDGE BRIAN RAYMOND (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
LILLY CO ELI	44	1991–2016
ATHENA NEUROSCIENCES INC	12	1999–2008
ELAN PHARM INC	5	2001–2005
REEL JON KEVINself	2	2011–2012
BERRIDGE BRIAN RAYMOND	1	2011

Locations

Location	Patents	Span
Carmel, IN, US	41	1994–2016
Indianapolis, IN, US	4	1991–1996